A Prospective Study of Clinical and Functional Outcome of Lateral Epicondylitis Treated With Platelet Rich Plasma
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 5, Pages 173-176
AbstractBackground: Lateral epicondylitis treatment is still remains a difficult task; the use of platelet-rich plasma (PRP) is a proactive therapeutic option that jump starts the healing process, which contains several different growth factors and other cytokines that stimulate healing of bone and soft tissue.
Materials and Methods: This is a prospective study of 100 patients, done at Narayana medical college and hospital, Nellore, Andhra Pradesh for 2 years. The primary analysis included visual analog scale pain scale, for measuring pain in patients, local tenderness, pain on extension of the wrist, grip strength, elbow swelling were clinically assessed at different interval of follow-up, clinical and functional outcome were evaluated at final follow-up with statistics.
Results: Results were calculated based on descriptive statistics with SPSS version 19. The average follow-up was 1year. Results were excellent in 80, good in 10, fair in 5 and poor in 3. In two cases, there was superficial infection seen.
Conclusion: Treatment with PRP holds promising results with minimal risk for the treatment of lateral epicondylitis. A more scientific evidence studies need to done before we can determine whether PRP therapy is effective in other conditions. PRP therapy as a viable procedure that may decrease the progression of more injuries may decrease the overall time for healing, and therefore, may setback the overall need for surgical intervention.
- Article View: 38
- PDF Download: 28